Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovaresist: Tamoxifen vs Chemotherapy in Resistant Ovarian Cancer
NCT02728622Phase 3Completed
- Sponsor
- Nordic Society of Gynaecological Oncology Clinical Trial Unit
- Start
- Mar 2002
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tamoxifen in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Nordic Society of Gynaecological Oncology Clinical Trial Unit. Started Mar 2002; status: completed.
02
Drugs
tamoxifen
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02728622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728622.